DK1083900T3 - Anvendelse af oxazolidinoner til fremstilling af et medikament til transdermal tilførsel - Google Patents

Anvendelse af oxazolidinoner til fremstilling af et medikament til transdermal tilførsel

Info

Publication number
DK1083900T3
DK1083900T3 DK99925598T DK99925598T DK1083900T3 DK 1083900 T3 DK1083900 T3 DK 1083900T3 DK 99925598 T DK99925598 T DK 99925598T DK 99925598 T DK99925598 T DK 99925598T DK 1083900 T3 DK1083900 T3 DK 1083900T3
Authority
DK
Denmark
Prior art keywords
oxazolidinones
drug
preparation
transdermal administration
infections
Prior art date
Application number
DK99925598T
Other languages
English (en)
Inventor
Charles W Ford
Jeffrey L Watts
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1083900T3 publication Critical patent/DK1083900T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DK99925598T 1998-06-05 1999-05-26 Anvendelse af oxazolidinoner til fremstilling af et medikament til transdermal tilførsel DK1083900T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8828398P 1998-06-05 1998-06-05
PCT/US1999/010463 WO1999062504A2 (en) 1998-06-05 1999-05-26 Topical administration of oxazolidinones for transdermal delivery

Publications (1)

Publication Number Publication Date
DK1083900T3 true DK1083900T3 (da) 2002-11-04

Family

ID=22210475

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99925598T DK1083900T3 (da) 1998-06-05 1999-05-26 Anvendelse af oxazolidinoner til fremstilling af et medikament til transdermal tilførsel

Country Status (29)

Country Link
US (2) US6613349B2 (da)
EP (1) EP1083900B1 (da)
JP (1) JP2002516852A (da)
KR (1) KR100626781B1 (da)
CN (1) CN1168447C (da)
AT (1) ATE220548T1 (da)
AU (1) AU749523B2 (da)
BR (1) BR9910318A (da)
CA (1) CA2327326A1 (da)
CO (1) CO5011042A1 (da)
CZ (1) CZ292420B6 (da)
DE (1) DE69902170T2 (da)
DK (1) DK1083900T3 (da)
EA (1) EA003699B1 (da)
ES (1) ES2179658T3 (da)
HK (1) HK1036593A1 (da)
HU (1) HU225234B1 (da)
ID (1) ID23775A (da)
IL (1) IL139843A0 (da)
MY (1) MY122454A (da)
NO (1) NO20006161D0 (da)
NZ (1) NZ508636A (da)
PL (1) PL193535B1 (da)
PT (1) PT1083900E (da)
SK (1) SK285352B6 (da)
TR (1) TR200003205T2 (da)
TW (1) TWI224000B (da)
WO (1) WO1999062504A2 (da)
ZA (1) ZA200005886B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562820B2 (en) * 2000-07-05 2003-05-13 Pharmacia & Upjohn Company Method for treatment and prevention of mastitis
WO2003030906A1 (en) * 2001-10-11 2003-04-17 Pharmacia & Upjohn Company Treating infections by administration of oxazolidinones to the skin
BR0308806A (pt) * 2002-03-29 2005-01-04 Upjohn Co Uso de oxazolidinonas para tratar infecções do tipo pé diabético
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
CN112409285A (zh) * 2020-11-30 2021-02-26 山东金城昆仑药业有限公司 噁唑烷酮类化合物的晶型及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3743727A (en) 1970-11-16 1973-07-03 Crown Zellerbach Corp Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide
US4507287A (en) 1983-06-20 1985-03-26 Dixon Glen J Preparation and method for the treatment of acne
JP2558107B2 (ja) 1986-12-18 1996-11-27 第一製薬株式会社 外用剤
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4960771A (en) * 1988-07-12 1990-10-02 Rajadhyaksha Vithal J Oxazolidinone penetration enhancing compounds
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164510A (en) 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
US5231188A (en) * 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
AU667198B2 (en) 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CN1046276C (zh) * 1993-11-22 1999-11-10 法玛西雅厄普约翰美国公司 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途
DE4425613A1 (de) 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
PT781122E (pt) 1994-09-14 2000-11-30 Minnesota Mining & Mfg Matriz para a distribuicao transdermica de farmacos
US5604262A (en) * 1995-03-22 1997-02-18 Research Corporation Technologies, Inc. Topical antimicrobial agents
ZA968661B (en) * 1995-11-17 1998-04-14 Upjohn Co Oxazolidinone antibacterial agent with tricyclic substituents.
ES2188940T3 (es) 1996-05-10 2003-07-01 Upjohn Co Administracion topica de premafloxacina para el tratamiento de enfermedades bacterianas sistemicas.
US5929086A (en) 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
US6040306A (en) * 1997-11-18 2000-03-21 Pharmacia & Upjohn Company Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
US6312715B1 (en) 1998-05-01 2001-11-06 3M Innovative Properties Company Adhesive microsphere drug delivery composition
US6174878B1 (en) * 1999-08-31 2001-01-16 Alcon Laboratories, Inc. Topical use of kappa opioid agonists to treat otic pain

Also Published As

Publication number Publication date
CZ292420B6 (cs) 2003-09-17
EA200100010A1 (ru) 2001-06-25
EP1083900A2 (en) 2001-03-21
MY122454A (en) 2006-04-29
EP1083900B1 (en) 2002-07-17
PL193535B1 (pl) 2007-02-28
HU225234B1 (en) 2006-08-28
US20040072841A1 (en) 2004-04-15
CN1168447C (zh) 2004-09-29
NO20006161L (no) 2000-12-04
US6613349B2 (en) 2003-09-02
AU749523B2 (en) 2002-06-27
HUP0102191A3 (en) 2003-07-28
ID23775A (id) 2000-05-11
JP2002516852A (ja) 2002-06-11
SK285352B6 (sk) 2006-11-03
DE69902170D1 (de) 2002-08-22
HK1036593A1 (en) 2002-01-11
US20020009483A1 (en) 2002-01-24
ES2179658T3 (es) 2003-01-16
TWI224000B (en) 2004-11-21
CZ20004432A3 (cs) 2001-03-14
AU4184899A (en) 1999-12-20
CO5011042A1 (es) 2001-02-28
EA003699B1 (ru) 2003-08-28
ATE220548T1 (de) 2002-08-15
PL345119A1 (en) 2001-12-03
BR9910318A (pt) 2001-01-30
WO1999062504A3 (en) 2000-02-24
NO20006161D0 (no) 2000-12-04
PT1083900E (pt) 2002-12-31
ZA200005886B (en) 2002-04-22
WO1999062504A2 (en) 1999-12-09
HUP0102191A2 (hu) 2002-05-29
IL139843A0 (en) 2002-02-10
DE69902170T2 (de) 2003-03-13
KR100626781B1 (ko) 2006-09-22
KR20010052555A (ko) 2001-06-25
CN1298302A (zh) 2001-06-06
SK16262000A3 (sk) 2001-06-11
TR200003205T2 (tr) 2001-05-21
CA2327326A1 (en) 1999-12-09
US7892574B2 (en) 2011-02-22
NZ508636A (en) 2002-03-01

Similar Documents

Publication Publication Date Title
US6264927B1 (en) Topical solution and method for the treatment of nail fungus
Reyzelman et al. Are antibiotics necessary in the treatment of locally infected ingrown toenails?
HUP9901991A2 (hu) Transzdermális eszköz flurbiprofén átadására
BRPI0410542A (pt) dispositivo de administração de medicamento para um olho e método de administrar um agente farmaceuticamente ativo a um olho
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
DE69628783D1 (de) Hydrogelbildende, selbst-solvatisierende, absorbierbare Polyestercopolymere sowie Verfahren zu deren Verwendung
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
DK0538302T3 (da) Reduktion eller forhindring af hudirritation forårsaget af lægemidler
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
PT904067E (pt) Dextrometorfan como agente antitussico administrado transdermicamente
DK1083900T3 (da) Anvendelse af oxazolidinoner til fremstilling af et medikament til transdermal tilførsel
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
ATE304886T1 (de) Oxazolidinones zur behandlung von augeninfektionen
DK1455849T3 (da) Sårbehandlingsanordning
BR0011880A (pt) Método para o tratamento de condições co-mórbidas associadas com obesidade, composto, produto, uso de um composto, e, composição farmacêutica
BR0104586A (pt) Método para tratamento de neurodegeneração
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
ECSP992967A (es) Aplicación topica de oxazolidinonas para administracion transdermica
DK1150981T3 (da) Terapeutisk necleosidforbindelse
TH57851B (th) การให้ออกซาโซลิดิโนนเฉพาะที่สำหรับการส่งผ่านทางผิวหนัง
TH57851A3 (th) การให้ออกซาโซลิดิโนนเฉพาะที่สำหรับการส่งผ่านทางผิวหนัง
RU99110181A (ru) Способ профилактики нагноения донорской раны после забора расщепленного кожного аутотрансплантата у больных с послеоперационными грыжами при наличии очагов хронической инфекции
NO20030483D0 (no) Assosiasjoner av dalfopristin/quinupristin med cefpirom
UA35107A (uk) Спосіб місцевого лікування ранової поверхні